Farabi Pharmaceutical (XTEH:DFRB1) Probability of Financial Distress (%)


What is Farabi Pharmaceutical Probability of Financial Distress (%)?

Farabi Pharmaceutical does not have enough data to calculate Probability of Financial Distress (%).


Farabi Pharmaceutical  (XTEH:DFRB1) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.


Farabi Pharmaceutical Probability of Financial Distress (%) Related Terms


Farabi Pharmaceutical Probability of Financial Distress (%) Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Probability of Financial Distress (%) Chart

Farabi Pharmaceutical Annual Data
Trend
Probability of Financial Distress (%)

Farabi Pharmaceutical Quarterly Data
Probability of Financial Distress (%)

XTEH:DFRB1 vs IMNPQ, INNV: Probability of Financial Distress (%) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farabi Pharmaceutical Probability of Financial Distress (%) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Probability of Financial Distress (%) falls into.



Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.